Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Walgreens Boots Alliance Inc    

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Costco says cooperating with DEA probe on controlled substances

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/17/2013 | 12:05am CET

Costco Wholesale Corp (>> Costco Wholesale Corporation) said on Wednesday that it will cooperate with the U.S. Drug Enforcement Administration in its ongoing investigation of prescriptions for controlled substances, after receiving subpoenas and warrants from the DEA.

Costco Wholesale Corp (>> Costco Wholesale Corporation) said on Wednesday that it will cooperate with the U.S. Drug Enforcement Administration in its ongoing investigation of prescriptions for controlled substances, after receiving subpoenas and warrants from the DEA.

The DEA has targeted large pharmacy chains and distributors to stem the flow of prescription drugs where abuse is suspected.

The DEA revoked the controlled substance licenses of two CVS Caremark Corp (>> CVS Caremark Corporation) drugstores in Florida in 2012, and earlier this year Walgreen Co (>> Walgreen Company) reached a record $80 million settlement with the agency to resolve allegations that its negligence in record-keeping and dispensing allowed highly addictive drugs to reach abusers and be sold illegally.

Costco announced its plans to cooperate with the DEA's subpoenas and administrative inspection warrants in a filing with the U.S. Securities and Exchange Commission on Wednesday. It said the matter concerned its "fulfillment of prescriptions related to controlled substances and related practices."

Additional details were not provided, and company representatives declined to comment beyond what was included in the regulatory filing.

(Reporting by Jessica Wohl in Chicago; Editing by Leslie Adler and Bob Burgdorfer)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on WALGREENS BOOTS ALLIANCE I
07:36p WALGREENS : Flu Index™ for Week of March 19, 2017
03/20 Fred's pharmacy schedules fourth quarter and full-year 2016 earnings; announc..
03/16 WALGREENS BOOTS ALLIANCE : Flu Index for Week of March 12, 2017; El Paso and Tyl..
03/15 WALGREENS : Flu Index™ for Week of March 12, 2017
03/10 WALGREENS BOOTS ALLIANCE : Publishes Corporate Social Responsibility Report 2016
03/09 WALGREENS BOOTS ALLIANCE : Flu Index for Week of March 5, 2017; Tyler, Texas and..
03/08 WALGREENS : Flu Index™ for Week of March 5, 2017
03/07 WALGREENS BOOTS ALLIANCE : Schedules Fiscal 2017 Second Quarter Earnings Announc..
03/02 WALGREENS BOOTS ALLIANCE : Flu Index for Week of Feb. 26, 2017; Greensboro, N.C...
03/01 WALGREENS : Flu Index™ for Week of Feb. 26, 2017
More news
Sector news : Drug Retailers - NEC
03/08DJHealth Costs Get a Rethink -- WSJ
02/14DJEXPRESS SCRIPTS : Revenue Falls
02/09DJCVS HEALTH : Profit Rises, Helped by Pharmacy Strength -- Update
02/09DJCVS HEALTH : Profit Rises, Helped by Pharmacy Strength
02/07DJCARDINAL HEALTH : Again Trims 2017 Profit Forecast
More sector news : Drug Retailers - NEC
Advertisement
Financials ($)
Sales 2017 118 792 M
EBIT 2017 7 496 M
Net income 2017 4 934 M
Debt 2017 8 289 M
Yield 2017 1,80%
P/E ratio 2017 18,20
P/E ratio 2018 16,39
EV / Sales 2017 0,83x
EV / Sales 2018 0,77x
Capitalization 89 818 M
More Financials
Chart WALGREENS BOOTS ALLIANCE I
Duration : Period :
Walgreens Boots Alliance I Technical Analysis Chart | US9314221097 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 94,6 $
Spread / Average Target 14%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Alexander W. Gourlay Co-Chief Operating Officer
George Rollo Fairweather Global Chief Financial Officer & Executive VP
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
WALGREENS BOOTS ALLIAN..-0.07%89 818
WALGREENS BOOTS ALLIAN..0.54%89 818
CVS HEALTH CORP-0.38%80 630
EXPRESS SCRIPTS HOLDIN..-7.20%38 324
MCKESSON CORPORATION3.95%30 960
CARDINAL HEALTH INC13.17%25 694
More Results